Table 4.

Percentage of patients that had correct and incorrect identification of side effects of the proposed checkpoint inhibitor in the post-conversation interview

Side Effect	Correct Identification N=72 (%)	Incorrect Identification N=23 (%)
Colon Issues/ Diarrhea	19 (26.39)	1 (4.17)
Nausea/Vomiting/Stomach Problems	-	11 (45.83)
Skin Issues	11 (15.28)	1 (4.17)
Hormone Problems	10 (13.89)	-
Lung Issues	8 (11.11)	-
Liver Problems	6 (8.33)	-
Flu-like symptoms	5 (6.94)	2 (8.33)
Heart Problems	5 (6.94)	-
Pancreas Issues	-	1 (4.17)
Kidney Problems	4 (5.56)	-
Fatigue	1 (1.39)	2 (8.33)
Depression	1 (1.39)	-
Diabetes	1 (1.39)	-
Arthritis	1 (1.39)	-
Autoimmune Conditions (Lupus, Crohns Disease)	-	3 (12.5)
Blood Counts Drop	-	1 (4.17)
Neuropathy	-	1 (4.17)
Hair Loss	-	1 (4.17)